Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid–induced differentiation of acute promyelocytic leukemia cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid–induced differentiation of acute promyelocytic leukemia cells
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 28, Issue 5, Pages 2009-2019
Publisher
FASEB
Online
2014-02-13
DOI
10.1096/fj.13-244368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
- (2016) Linda S. Steelman et al. Aging-US
- Identification of the PKR Nuclear Interactome Reveals Roles in Ribosome Biogenesis, mRNA Processing and Cell Division
- (2013) William L. Blalock et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phosphoinositide-specific Phospholipase C β 1b (PI-PLCβ1b) Interactome: Affinity Purification-Mass Spectrometry Analysis of PI-PLCβ1b with Nuclear Protein
- (2013) Manuela Piazzi et al. MOLECULAR & CELLULAR PROTEOMICS
- Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells
- (2013) K Kurokawa et al. ONCOGENE
- The emerging multiple roles of nuclear Akt
- (2012) Alberto M. Martelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Targeting the PI3K signaling pathway in cancer therapy
- (2012) Chandra Bartholomeusz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance
- (2012) Rong Jia et al. International Journal of Biological Sciences
- GSK3 is a regulator of RAR-mediated differentiation
- (2012) K Gupta et al. LEUKEMIA
- Aberrant Expression of Splicing Factors in Newly Diagnosed Acute Myeloid Leukemia
- (2012) Jing Liu et al. ONKOLOGIE
- CaMK IV phosphorylates prohibitin 2 and regulates prohibitin 2-mediated repression of MEF2 transcription
- (2011) Luguo Sun et al. CELLULAR SIGNALLING
- Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway
- (2011) A M Martelli et al. LEUKEMIA
- Nucleolar proteins with altered expression in leukemic cell lines
- (2011) Kaisa J. Teittinen et al. LEUKEMIA RESEARCH
- Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration
- (2010) Graham M. Strub et al. FASEB JOURNAL
- The role of prohibitin in cell signaling
- (2010) Suresh Mishra et al. FEBS Journal
- Ribosomal Protein S3, a New Substrate of Akt, Serves as a Signal Mediator between Neuronal Apoptosis and DNA Repair
- (2010) Sang Bae Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress
- (2010) W L Blalock et al. LEUKEMIA
- How I treat acute promyelocytic leukemia
- (2009) M. S. Tallman et al. BLOOD
- The SR protein family of splicing factors: master regulators of gene expression
- (2008) Jennifer C. Long et al. BIOCHEMICAL JOURNAL
- Retinoic acid receptors, hematopoiesis and leukemogenesis
- (2008) Steven J Collins CURRENT OPINION IN HEMATOLOGY
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now